http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP12012147-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695
filingDate 2012-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc45da07885af9bd78c1622e73886f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58c1bf299cef9162607af8b69191b3f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6c8804f04e9a6f7147ab45cc80bb2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ea83499ca8b9e4cda858a7112fad29b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b9b9ac14f915dbf5213d10f0f6cce05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b150a081799c8628580448941698fbff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee0a178a3f902793afd0014ef2ecd9ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45cac683416f0f595010e8d0b6216a68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee3b44e3cca92721e5d1c8f92964dcdd
publicationDate 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP12012147-A
titleOfInvention FUSIONED TRICHYCLIC SILILO COMPOUNDS AND METHODS OF USE OF THE SAME FOR THE TREATMENT OF VIRAL DISEASES
abstract The present invention relates to new Fused Tricyclic Silyl Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, B, C, D, M1, X1 and X2 are as defined in present document The present invention also relates to compositions comprising at least one Fused Tricyclic Silyl Compound, and methods of using the Fused Tricyclic Silyl Compounds to treat or prevent an HCV infection in a patient.
priorityDate 2010-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458433570

Total number of triples: 26.